TG Therapeutics
「TG Therapeutics」熱門搜尋資訊
「TG Therapeutics」文章包含有：「ABOUTUS」、「OurProducts」、「OVERVIEW」、「OVERVIEWPIPELINE」、「PressReleases」、「TGTherapeutics,Inc.(TGTX)StockPrice」、「TGTherapeutics」、「TGTherapeutics」、「TGTherapeutics」、「TGTX-TGTherapeutics,Inc.」
查看更多
ABOUT US
https://www.tgtherapeutics.com
TG Therapeutics was founded with one goal in mind—to leverage scientific advances in B-cell biology to develop novel treatments for patients.
Our Products
https://www.tgtherapeutics.com
Fiercely Focused On Treatments. BRIUMVI® (ublituximab-xiiy).
OVERVIEW
https://www.tgtherapeutics.com
An external clinical trials network composed of over 200 community and academic clinical trial sites globally, specializing in B-cell diseases.
OVERVIEW PIPELINE
https://www.tgtherapeutics.com
OUR PIPELINE ; Ublituximab monotherapy: glycoengineered anti-CD20 mAb, Relapsing MS. ULTIMATE I and II ; TG-1801: anti-CD47/CD19 bispecific mAb, B-cell disorders.
Press Releases
https://ir.tgtherapeutics.com
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting. NEW ...
TG Therapeutics, Inc. (TGTX) Stock Price
https://finance.yahoo.com
TG Therapeutics Inc (NASDAQ:TGTX) reported a total net revenue of $165.8 million for Q3 2023, including BRIUMVI net sales of $25.1 million in the United States.
TG Therapeutics
https://hk.finance.yahoo.com
TGTX - TG Therapeutics, Inc. · 13 Stocks to Buy with Exponential Growth · 15 Best U.S. Stocks to Buy Now Under $10 · 3 Very Oversold Biotech Stocks to Buy Right ...
TG Therapeutics
https://ir.tgtherapeutics.com
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.
TG Therapeutics
https://www.tgtherapeutics.com
BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and ...
TGTX-TG Therapeutics, Inc.
https://www.moneydj.com
TG Therapeutics, Inc. · 2 Gansevoort Street,9th Floor,New York,New York 10014,United States Of America · 1,542,990,704 (2023/11/10) · 226 ...